What is Next for the Genetics of Multiple Sclerosis?

Winiarek, D. J. K., Szpakowski, P., & Glabinski, A. (2015). Neural Plasticity in Multiple Sclerosis: The Functional and Molecular Background. Neural Plasticity, 2015(), 375-385-031. https://doi.org/10.1155/2015/307175
Lensch, E., & Jost, W. H. (2011). Autonomic Disorders in Multiple Sclerosis. Autoimmune Diseases, 2011(), 171-176. https://doi.org/10.4061/2011/803841
Bermel, R., Waldman, A., & Mowry, E. M. (2014). Outcome Measures in Multiple Sclerosis. Multiple Sclerosis International, (2014), 92-93. https://doi.org/10.1155/2014/439375
Schreiner, T. L., & Miravalle, A. (2012). Current and merging Therapies for the Treatment of Multiple Sclerosis: Focus on Cladribine. Journal of Central Nervous System Disease, (), 1-14. https://doi.org/10.4137/JCNSD.S5128
Kawamoto, E., Nakahashi, S., Okamoto, T., Imai, H., & Shimaoka, M. (2012). Anti-Integrin Therapy for Multiple Sclerosis. Autoimmune Diseases, 2012(), 163-168. https://doi.org/10.1155/2012/357101